Year 11 pupils at several schools in Kent are to be offered vaccinations against meningitis B, as health officials move to contain an unusual and fast-moving outbreak that has tragically claimed two young lives.
The UK Health Security Agency confirmed the expansion of the programme on Monday, stating it was a precaution to ensure long-term protection. It follows the vaccination of University of Kent students, which began on 18 March, and an earlier extension to sixth-form pupils at four affected schools. The Health Secretary, Wes Streeting, has now asked the Joint Committee on Vaccination and Immunisation to re-examine national eligibility for the MenB vaccine, which is currently only routinely offered on the NHS to babies born after May 2015 and those with specific medical conditions.
To date, the public health response has seen more than 13,000 antibiotic doses and over 10,000 vaccine doses administered. A targeted vaccination programme was initially rolled out for students in University of Kent halls of residence, and has since been extended to all individuals offered preventative antibiotics. However, reports of students being turned away from vaccine queues and pharmacies facing private supply constraints highlight the heightened demand and the gap in the national immunisation schedule for teenagers.
Scale and focus of the outbreak
The latest figures from the UKHSA show 20 confirmed cases, with a further three under investigation as of Monday afternoon—a fall from 29 total reported the previous day. All those affected have been admitted to hospital, with nine known to have required intensive care.
The two students who died are 18-year-old Juliette Kenny, described by her family as “fit, healthy and strong,” and another University of Kent student. The father of Juliette Kenny has spoken of the devastating speed of her death, saying she fell ill just 12 hours before passing away, and has called for urgent reform of vaccine access for teenagers.
According to a UKHSA technical report, the earliest known case fell ill on 9 March, with the most recent on 16 March. The peak of the outbreak was 13 March. The median age of cases is 19, and 18 of the 23 are known to be students. The report states that “the majority of outbreak cases have been found to have an epidemiological link with a club in Canterbury,” with 20 of the 23 people known to have attended Club Chemistry at least once before becoming unwell. The nightclub, a focal point of the investigation, remains closed.
The science behind the outbreak’s speed
While experts stress that outbreaks in young adults are not unexpected—university students have an estimated 11 times higher risk of meningococcal disease than non-students of the same age—the UKHSA confirms the Kent outbreak is of an unusual size and pace. The agency attributes this to a combination of three specific factors: the nature of the bacterial strain involved, levels of population immunity, and social and environmental factors.
Genetic sequencing on one case has revealed the strain is a new variant of a group B meningococci subtype that has been present in England since 2020. The UKHSA states this strain responds to antibiotics and MenB vaccines, but work is under way to explore whether its multiple genetic differences could affect its biology, for example by increasing transmissibility or disease potential.
Social and environmental factors are considered critical. The outbreak is strongly linked to attendance at Club Chemistry between 5 and 7 March. Meningococcal disease requires close and prolonged contact to spread, such as living together or intimate contact like kissing or sharing items such as drinks and vapes—behaviours common in nightlife and student accommodation settings.
Furthermore, experts are investigating whether co-circulating viruses may have played a role. Viral infections that damage the lining of the nose and throat can make it easier for the bacteria to enter the bloodstream. Studies are also being carried out to assess susceptibility to this specific outbreak strain, with initial work focused on young people aged 15 to 22.
The UKHSA currently assesses the level of transmission at level 1.1, meaning there is a known cluster with a small number of directly linked cases, all acquired in Kent. However, the agency’s report adds it is highly likely that in the next four weeks there may be cases where infections are acquired outside the county.
Dr Merav Kliner, an incident director at UKHSA, reiterated the importance of vigilance, stating that while antibiotics and vaccinations had been offered to contacts, everyone should remain aware of the signs and symptoms. “We also see more than 350 cases of meningococcal infection across the country each year,” she added, urging the public to seek rapid medical attention if concerned.